Unigestion Holding SA Has $869,000 Stock Holdings in HCP, Inc. (NYSE:HCP)

Unigestion Holding SA cut its holdings in HCP, Inc. (NYSE:HCP) by 98.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 24,400 shares of the real estate investment trust’s stock after selling 1,991,900 shares during the quarter. Unigestion Holding SA’s holdings in HCP were worth $869,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Quest Capital Management Inc. ADV acquired a new stake in shares of HCP in the third quarter valued at $28,000. Westside Investment Management Inc. bought a new position in HCP in the second quarter valued at about $31,000. Bartlett & Co. LLC bought a new position in HCP in the third quarter valued at about $36,000. NEXT Financial Group Inc boosted its holdings in HCP by 181.3% in the second quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock valued at $36,000 after acquiring an additional 725 shares during the last quarter. Finally, CSat Investment Advisory L.P. boosted its holdings in HCP by 77.6% in the second quarter. CSat Investment Advisory L.P. now owns 1,165 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 509 shares during the last quarter. Institutional investors own 95.80% of the company’s stock.

HCP traded down $0.89 during midday trading on Friday, reaching $33.64. 4,003,528 shares of the company were exchanged, compared to its average volume of 2,801,829. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.81 and a current ratio of 0.81. HCP, Inc. has a one year low of $26.58 and a one year high of $37.93. The stock has a market capitalization of $17.57 billion, a P/E ratio of 18.48, a PEG ratio of 6.81 and a beta of 0.22. The stock’s 50-day simple moving average is $36.24 and its 200 day simple moving average is $33.42.

HCP (NYSE:HCP) last issued its earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.52). HCP had a return on equity of 12.78% and a net margin of 43.66%. The company had revenue of $538.00 million for the quarter, compared to the consensus estimate of $503.65 million. During the same quarter last year, the business posted $0.44 EPS. HCP’s quarterly revenue was up 18.0% on a year-over-year basis. On average, research analysts anticipate that HCP, Inc. will post 1.75 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th will be issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 4.40%. The ex-dividend date is Friday, November 1st. HCP’s dividend payout ratio (DPR) is currently 81.32%.

In other HCP news, COO Thomas Klaritch sold 35,014 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $36.02, for a total transaction of $1,261,204.28. Following the transaction, the chief operating officer now owns 230,529 shares in the company, valued at $8,303,654.58. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.13% of the stock is currently owned by company insiders.

Several research firms recently issued reports on HCP. JPMorgan Chase & Co. upgraded HCP from a “neutral” rating to an “overweight” rating and raised their price target for the company from $35.00 to $38.00 in a report on Tuesday, October 8th. Morgan Stanley raised their price target on HCP from $32.00 to $35.00 and gave the company an “equal weight” rating in a report on Tuesday, September 17th. Scotiabank set a $38.00 price target on HCP and gave the company a “buy” rating in a report on Monday, September 30th. KeyCorp raised their price target on HCP from $34.00 to $37.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Finally, TheStreet upgraded HCP from a “c+” rating to a “b-” rating in a report on Friday, August 2nd. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. HCP presently has a consensus rating of “Buy” and an average target price of $36.78.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: What does a dividend yield signify to investors?

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.